Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

By Ingle J.N.   Suman V.J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite

Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy

By Smith I.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 289-293

Elsevier

Access to resources Recommend Favorite

Aromatase and cyclooxygenases: enzymes in breast cancer

By Brueggemeier R.W.   Richards J.A.   Petrel T.A.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 501-507

Elsevier

Access to resources Recommend Favorite

Aromatase inhibitors as adjuvant therapies in patients with breast cancer

By Coombes R.C.   Gibson L.   Hall E.   Emson M.   Bliss J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 309-311

Elsevier

Access to resources Recommend Favorite

The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease

By de Jong P.C.   Blankenstein M.A.   Nortier J.W.R.   Slee P.H.T.J.   van de Ven J.   van Gorp J.M.H.H.   Elbers J.R.J.   Schipper M.E.I.   Blijham G.H.   Thijssen J.H.H.   Lu Q.   Jelovac D.   Brodie A.M.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 87, Iss. 2, 2003-11 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite